CLINICAL_TRIALS
trial_result
· 2010-02-04
Clinical Trial Update: Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Breast Cancer [Phase 2]
Summary
A Phase II study evaluating weekly paclitaxel (BMS-181339) for breast cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED